CATHERINE MOORE: Open Payments
NPI 1942614250 · SAINT LOUIS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$524 in 26 payments from 10 companies in 2025. Trend: 2023 $327 · 2024 $378 · 2025 $524
Food & beverage: $524
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 4 | $113 |
| Exact Sciences Corporation | 5 | $92 |
| Novo Nordisk Inc | 5 | $91 |
| Lilly USA, LLC | 2 | $49 |
| Hologic Sales and Service, LLC | 2 | $45 |
| ABBVIE INC. | 2 | $40 |
| GlaxoSmithKline, LLC. | 2 | $37 |
| Amgen Inc. | 2 | $28 |
| AstraZeneca Pharmaceuticals LP | 1 | $15 |
| SANOFI PASTEUR INC. | 1 | $15 |
Products named: Cologuard Collection Kit, Ozempic, MOUNJARO, MAVYRET, BEXSERO, Rybelsus, APTIMA, THIRD WAVE.
Industry payments across MO — which companies pay providers there.
